Atlas Trials

Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects

Clinical trial NCT02146625 · COMPLETED

Trial details

NCT number
NCT02146625
Sponsor
HK inno.N Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-11-01
Primary completion
2015-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.